IRVINE, Calif., May 6, 2014 (GLOBE NEWSWIRE) -- Sabra Health Care REIT, Inc. ("Sabra") (Nasdaq:SBRA) announced today that it plans to offer 7,000,000 shares of its common stock in an underwritten public offering. In connection with the offering, Sabra expects to grant the underwriters a 30-day option to purchase up to 1,050,000 additional shares of its common stock.
Sabra intends to use a portion of the net proceeds from the offering to repay borrowings outstanding on Sabra's revolving credit facility. The remaining proceeds to Sabra will be used to fund possible future acquisitions or for general corporate purposes.
Citigroup Global Markets Inc., BofA Merrill Lynch, Wells Fargo Securities, LLC, Barclays Capital Inc. and RBC Capital Markets, LLC are acting as joint book-running managers for this offering. Raymond James & Associates, Inc. and Stifel are acting as co-managers.The offering is being conducted pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. This press release does not constitute an offer to sell or a solicitation of any offer to buy the shares of Sabra's common stock described herein, nor shall there be any offer, solicitation or sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. The offering of these securities is being made solely by means of a prospectus supplement and the accompanying prospectus. Copies of the prospectus supplement and accompanying prospectus can be obtained by written request to: Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at 800-831-9146; BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department or by e-mail at firstname.lastname@example.org; or Wells Fargo Securities, 375 Park Avenue, New York, NY 10152, Attention: Equity Syndicate Dept., or by telephone at 800-326-5897.
CONTACT: Investor & Media Inquiries: (949) 679-0410
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts